Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Amoxicillin / Clavulanic Acid bulk supplier for pharma manufacturers

Amoxicillin / Clavulanic Acid Suppliers & Bulk Manufacturers

Available Forms: Tablets, Oral suspension, Sachets and Chewables

Available Strengths: All Forms in US: 250/125 mg to 1000/62.5 mg; For EU: 250/125 mg to 1000/125 mg

Reference Brands: Clavulin, Augmentin(Eu & US), Moxiclav (India)

Category: Respiratory Disorder

Amoxicillin + Clavulanic Acid (Co-amoxiclav) is a broad-spectrum antibiotic used for respiratory and other infections. Available in the US and EU as tablets, chewables, and suspensions under brands like Augmentin®, it offers strong bacterial coverage and is ideal for B2B, PCD, and global pharma markets.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Amoxicillin + Clavulanic Acid, also known as co-amoxiclav, is a powerful broad-spectrum antibiotic combination used to treat respiratory infections, sinusitis, otitis media, and skin infections. Available in the US and EU under brands like Augmentin®, Clavulin®, and generics, it comes in tablets (250/125 mg to 1000/125 mg), chewables, and oral suspensions (125/31.25 mg to 600/42.9 mg per 5 mL). This combination enhances bacterial resistance coverage and is widely prescribed for both adults and children. Highly in demand for B2B, PCD, and global export markets, co-amoxiclav is a staple in respiratory and general infection treatment protocols worldwide.

Amoxicillin / Clavulanic Acid — third party manufacturing & bulk supply

Amoxicillin / Clavulanic Acid is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Amoxicillin / Clavulanic Acid is supplied as Tablets, Oral suspension, Sachets and Chewables — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Amoxicillin / Clavulanic Acid listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Amoxicillin / Clavulanic Acid →
Back to Listing

Frequently Asked Questions

Amoxicillin and clavulanic acid is used to treat a wide range of bacterial infections, including respiratory tract infections, sinusitis, ear infections, urinary tract infections, skin and soft tissue infections, and dental infections. The combination is especially useful for infections caused by bacteria that produce beta-lactamase enzymes, which can make them resistant to certain antibiotics.

Amoxicillin and clavulanic acid contains two active ingredients: amoxicillin trihydrate and clavulanate potassium (derived from clavulanic acid). Amoxicillin is a penicillin-class antibiotic that kills bacteria by inhibiting bacterial cell wall synthesis, while clavulanic acid acts as a beta-lactamase inhibitor that protects amoxicillin from bacterial resistance.

Amoxicillin and clavulanic acid is marketed under several trade names worldwide, including Augmentin, Clavulin, Amoclan, Curam, and Co-Amoxiclav.

The combination of amoxicillin and clavulanic acid was originally developed by Beecham Research Laboratories, which later became part of GlaxoSmithKline. Today, it is manufactured by many pharmaceutical companies globally as both branded and generic products.

The generic name is amoxicillin trihydrate and clavulanate potassium.

Brand names include Augmentin, Clavulin, Amoclan, Curam, Co-Amoxiclav, and several other branded generic versions marketed by pharmaceutical companies.

Amoxicillin and clavulanic acid is manufactured by numerous pharmaceutical companies worldwide in regulated and emerging pharmaceutical manufacturing markets.

Related Products

Cefpodoxime Proxetil

Strength:
Tab: 100 mg. 200 mg, Susp: 50 mg/5 mL, 100 mg/5 mL

Form: Tablets & oral suspension

Reference Brands: Sefpotec®(EU); Vantin®(US- Dis.cntd but generics avialble)

View Details
Ipratropium / Salbutamol Respules

Strength:
Ipratropium Bromide 0.5 mg + Albuterol Sulfate (equivalent to 3 mg salbutamol) 2.5 mg

Form: Nebulizer Solution

Reference Brands: EU : Combivent® Nebules, Ipramol Steri-Neb®, Duovent® Nebuliser Solution; US: DuoNeb®

View Details
Levofloxacin Tablet

Strength:
Tab: 250 mg, 500 mg, 750 mg; Oral Solution: 25 mg/mL

Form: Tablets & Oral Solution

Reference Brands: Levaquin®(US & EU); Tavanic®(EU/LATAM), Levox (India)

View Details
Budesonide Respules

Strength:
0.25 mg/2 mL, 0.5 mg/2 mL, 1 mg/2 mL

Form: Inhalation Suspension for Nebulization

Reference Brands: Pulmicort Respules®(US), Pulmicort Nebuliser Suspension, Budenofalk Nebuliser Suspension(EU)

View Details
Umeclidinium Bromide

Strength:
62.5 mcg

Form: dry-powder inhaler

Reference Brands: Incruse Ellipta (USA)

View Details
Nerandomilast

Strength:
10 mg

Form: Tablets

Reference Brands: Jascayd (USA/EU)

View Details
Levalbuterol

Strength:
0.31 mg, 0.63 mg, 1.25 mg

Form: Inhalation solution

Reference Brands: Xopenex (USA/EU)

View Details
Mepolizumab

Strength:
100 mg/1 mL

Form: injection (prefilled syringe)

Reference Brands: Nucala (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.